Cleared Special

K010821 - ECHOSEED/IODINE-125 SEEDS, MODEL 6733

K010821 is an FDA 510(k) clearance for ECHOSEED/IODINE-125 SEEDS, manufactured by Medi-Physics Inc. Dba Nycomed Amersham Imaging. The device is a Class 2 Radiology device with product code KXK cleared through the Special 510(k) pathway after a 23-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2001
Decision
23d
Days
Class 2
Risk

K010821 is an FDA 510(k) clearance for the ECHOSEED/IODINE-125 SEEDS, MODEL 6733. Classified as Source, Brachytherapy, Radionuclide (product code KXK), Class II - Special Controls.

Submitted by Medi-Physics Inc. Dba Nycomed Amersham Imaging (Arlington Heights, US). The FDA issued a Cleared decision on April 11, 2001 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K010821

510(k) Number K010821 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 19, 2001
Decision Date April 11, 2001
Days to Decision 23 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
84d faster than avg
Panel avg: 107d · This submission: 23d
Pathway characteristics
Modification to existing cleared device.

KXK Device Classification - Class 2, Special Controls

Product Code KXK Source, Brachytherapy, Radionuclide
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KXK Source, Brachytherapy, Radionuclide

All 150
Devices cleared under the same product code (KXK) and FDA review panel - the closest regulatory comparables to K010821.
BRACHYSEED PD-103 MODELS #PD1
K011119 · Draximage, Inc. · Jun 2001
THERASEED(R) PALLADIUM-103 IMPLANT
K010283 · Theragenics Corp. · Apr 2001
GLIASITE RADIATION THERAPY SYSTEM (RTS), MODEL 1020,1030,1040,8150,9005
K003206 · Proxima Therapeutics, Inc. · Apr 2001
SELECT SEED I-125
K002429 · Nucletron Corp. · Feb 2001
RADIOMED SOURCE
K001070 · Radiomed Corp. · Oct 2000
RE-ENTRANT CHAMBER, MODEL 1008 OR 44D
K002446 · Sun Nuclear Corp. · Oct 2000